Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02162706 · ClinicalTrials.gov registry record
Salivary Cortisol Measurements by Mass Spectrometry
A clinical trial of Endocrine Disorders, sponsored by Stanford University.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT02162706: Completed study of Endocrine Disorders, sponsored by Stanford University.
NCT02162706 is a study of Endocrine Disorders that has completed, run by Stanford University. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02162706, a study of Endocrine Disorders, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Cortisol is a hormone critical for survival in times of stress. Currently most measurements are done with blood samples. The hypothesis of this study is cortisol measured from saliva using mass spectrometry can be used to replace measurements by blood.
Conditions Studied
Interventions
- OTHER Non intervention study
Study Locations (1)
California
- Lucile Packard Children's Hospital and Stanford Clinics - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-03 |
What the finished NCT02162706 record still lists
NCT02162706 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 1 condition, with Endocrine Disorders appearing as the primary indexed condition, and to 1 intervention - of which Non intervention study is the first listed.
NCT02162706 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02162706 about?
NCT02162706 is a clinical study titled "Salivary Cortisol Measurements by Mass Spectrometry". Cortisol is a hormone critical for survival in times of stress. Currently most measurements are done with blood samples. The hypothesis of this study is cortisol measured from saliva using mass spectrometry can be used to replace measurements by blood.
What is the current status of trial NCT02162706?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-06. Estimated completion is 2016-03.
What conditions does trial NCT02162706 study?
This clinical trial studies the following conditions: Endocrine Disorders.
What interventions are being tested in trial NCT02162706?
The interventions under investigation include: Non intervention study (OTHER).
Who is sponsoring clinical trial NCT02162706?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02162706 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia